Pathogenic mtDNA mutations causing mitochondrial myopathy: the need for muscle biopsy

Pathogenic mitochondrial tRNA (mt-tRNA) gene mutations represent a prominent cause of primary mitochondrial DNA (mtDNA)-related disease despite accounting for only 5%-10% of the mitochondrial genome.(1,2) Although some common mt-tRNA mutations, such as the m.3243A>G mutation, exist, the major...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Hardy, S, Blakely, E, Purvis, A, Rocha, M, Ahmed, S, Falkous, G, Poulton, J, Rose, M, O'Mahony, O, Bermingham, N, Dougan, C, Ng, Y, Horvath, R, Turnbull, D, Gorman, G, Taylor, R
Formaat: Journal article
Taal:English
Gepubliceerd in: American Academy of Neurology 2016
Omschrijving
Samenvatting:Pathogenic mitochondrial tRNA (mt-tRNA) gene mutations represent a prominent cause of primary mitochondrial DNA (mtDNA)-related disease despite accounting for only 5%-10% of the mitochondrial genome.(1,2) Although some common mt-tRNA mutations, such as the m.3243A>G mutation, exist, the majority are rare and have been reported in only a small number of cases.(3) The MT-TP gene, encoding mt-tRNA(Pro), is one of the less polymorphic mt-tRNA genes, and only 5 MT-TP mutations have been reported as a cause of mitochondrial muscle disease to date (table e-1 at Neurology.org/ng, P6-10). We report 5 patients with myopathic phenotypes, each harboring different pathogenic mutations in the MT-TP gene, highlighting the importance of MT-TP mutations as a cause of mitochondrial muscle disease and the requirement to study clinically relevant tissue.